Work

Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward

Year: 2017
Type: review
Abstract: Over the past 20 years, there has been tremendous progress in retinal gene therapy. The safety and efficacy results in one early-onset severe blinding disease may lead to the first gene therapy drug approval in the United States. Here, we review how far the field has come over the past two decades and speculate on the directions that the field will take in the future.
Author: Jean Bennett
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W2598842955
FWCI: 2.628
Cites: 136
Cited by: 126
Related to: 10